FdaApplication

ANDA 200824

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRISING PHARMA HOLDINGS INC
application_typeANDA
approval_date2011-10-18

Products (5)

ProductActive ingredientStrengthDosage form
MORPHINE SULFATEMORPHINE SULFATE15MGTABLET, EXTENDED RELEASE;ORAL
MORPHINE SULFATEMORPHINE SULFATE100MGTABLET, EXTENDED RELEASE;ORAL
MORPHINE SULFATEMORPHINE SULFATE200MGTABLET, EXTENDED RELEASE;ORAL
MORPHINE SULFATEMORPHINE SULFATE30MGTABLET, EXTENDED RELEASE;ORAL
MORPHINE SULFATEMORPHINE SULFATE60MGTABLET, EXTENDED RELEASE;ORAL

5 products